Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Systems Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1557225

This article is part of the Research TopicIntegrated Diagnostics and Biomarker Discovery in Endocrinology and Biomedical Sciences: Volume IIView all 9 articles

Characteristics of the Gut Microbiome of Asymptomatic hyperuricemia

Provisionally accepted
Fengjiao  CaoFengjiao Cao*Wenming  YiWenming YiMengwei  WuMengwei WuAo  GaoAo GaoKang  TianlunKang TianlunXiujuan  HouXiujuan Hou
  • Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China

The final, formatted version of the article will be published soon.

Purpose: Asymptomatic hyperuricemia(AH) is characterized by elevated blood uric acid levels without symptoms,posing risks like gout, kidney stones, and cardiovascular diseases. This study aims to investigate the role of the gut microbiota in uric acid metabolism in AH. Methods: Clinical data from 30 AH patients and 30 healthy controls were collected. Fecal microbiota genomic DNA was extracted, PCR amplified, library constructed, and sequenced. Bioinformatics and statistical analyses were conducted to study the gut microbiota of the two groups. Results: The AH group exhibited significantly elevated levels of body mass index (BMI), Triglycerides (TG), Total Cholesterol (TC), as along with a history of smoking, hypertension, and fatty liver disease compared to the healthy group (P < 0.05). The overall richness and ecological diversity of gut microbiota in the AH group decreased, with differences in the distribution at the phylum and genus levels compared to the healthy group. Uric acid demonstrated significant correlations with various gut microbiota (e.g., Bulleidia and Granulicatella), suggesting their potential as biomarkers for AH. Despite limitations such as a small sample size and lack of long-term follow-up, our findings provide new insights for the early diagnosis and personalized treatment of AH. Looking ahead, these discoveries may advance the clinical management of AH and the exploration of associated biomarkers.

Keywords: Asymptomatic hyperuricemia, Gut Microbiota, 16S rRNA sequencing, correlation study, Clinical parameters

Received: 08 Jan 2025; Accepted: 19 Sep 2025.

Copyright: © 2025 Cao, Yi, Wu, Gao, Tianlun and Hou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Fengjiao Cao, yezi880602@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.